Based on your medical history and metabolic profile Guided by a licensed provider May include GLP-1/GIP medications when appropriate Focused on sustainable, long-term results Uses evidence-based treatments Instead of guessing what works, your plan is built around how your body responds
Looking Ahead GLP-1 drugs have revolutionized treatment for obesity, but recent regulatory activity is a reminder that existing rules apply even when the innovation is revolutionary
(28:23): And I think as we have more different kinds of medicines available in obesity, it's also a way to kind of compare how these different medicines work
Effective integration of PGx into clinical practice can make well-supported, accessible data a standard part of care
Key considerations include: Under-dosing risks: Insufficient receptor engagement may yield minimal benefit
Yes, registration is required to book an appointment